Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 2/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12802878 | 0.91 | CHRM2 (0.57) | CHRM2MEN1CYP1A2CYP2C19KMT2A | |
| SCHEMBL12803087 | 0.89 | CHRM2 (0.48) | CHRM2MEN1CYP1A2CYP2C19KMT2A | |
| SCHEMBL12486311 | 0.89 | CHRM2 (0.56) | CHRM2MEN1CYP1A2CYP2C19KMT2A | |
| SCHEMBL12486197 | 0.84 | CHRM2 (0.51) | CHRM2MEN1CYP1A2CYP2C19KMT2A | |
| SCHEMBL12482625 | 0.81 | CHRM2 (0.64) | CHRM2MEN1CYP1A2CYP2C19KMT2A | |
| SCHEMBL12486194 | 0.81 | CASP3 (0.44) | CHRM2MEN1CYP1A2CYP2C19KMT2A | |
| SCHEMBL2197282 | 0.79 | CHRM2 (0.47) | CHRM2MEN1CYP1A2CYP2C19KMT2A | |
| SCHEMBL12485341 | 0.79 | CHRM2 (0.47) | CHRM2MEN1CYP1A2CYP2C19KMT2A | |
| SCHEMBL12935859 | 0.79 | CHRM2 (0.66) | CHRM2MEN1CYP1A2CYP2C19KMT2A | |
| SCHEMBL12482194 | 0.77 | CHRM2 (0.63) | CHRM2MEN1CYP1A2CYP2C19KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2512409-B1 | PHTHALIMIDES AS BLEACH ACTIVATORS | HENKEL AG & CO KGAA (DE) | 2014-12-17 | — | — | EP | disclosed |
| EP-2512409-B1 | PHTHALIMIDES AS BLEACH ACTIVATORS | HENKEL AG & CO KGAA (DE) | 2014-12-17 | — | — | EP | disclosed |
| US-8328879-B2 | Phthalimides as bleach activators | HENKEL AG & CO. KGAA (DE) | 2012-12-11 | — | — | US | disclosed |
| US-20120246841-A1 | PHTHALIMIDES AS BLEACH ACTIVATORS | HENKEL AG & CO. KGAA (DE) | 2012-10-04 | — | — | US | disclosed |
| WO-2011079974-A2 | PHTALIMIDES AS BLEACH ACTIVATORS | HENKEL AG & CO. KGAA (DE) | 2011-07-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120246841-A1 | PHTHALIMIDES AS BLEACH ACTIVATORS | KRT18, PPOX, CRYAA | CHRM2 4093/4885MEN1 3342/4885CYP1A2 1967/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.